Germany · Delayed Price · Currency is EUR BRAIN Biotech AG Company Description
BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom.
The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubator. The BRAINBiocatalysts segment develops, produces, and distributes specialty enzymes, microorganisms, and ingredients.
The BRAINBioIncubator segment encompasses a pipeline of research-intensive development projects primarily for the life sciences industry.
The company offers enzymes, biocatalysts, microorganisms, and other bioactive natural compounds to produce foodstuffs and animal feed, cosmetics, and medical products, as well as for industrial applications in chemical companies, waste and hazardous materials disposal, and energy and raw materials production.
The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021.
BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.
| Country | Germany |
| Founded | 1993 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 292 |
| CEO | Adriaan Moelker |
Contact Details
Address: Darmstädter Strasse 34-36 Zwingenberg, 64673 Germany | |
| Phone | 49 62 51 9331 0 |
| Website | brain-biotech.com |
Stock Details
| Ticker Symbol | BNN |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | October - September |
| Reporting Currency | EUR |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Adriaan Moelker | Chief Executive Officer |
| Michael Schneiders | Chief Financial Officer |